Bicara Therapeutics Inc.
BCAX- Exchange
- Nasdaq
- Industry
- Pharmaceutical Preparations
- SEC CIK
- 0002023658
In the last 90 days, Bicara Therapeutics Inc. insiders filed 0 open-market purchases and 1 sale; 172 institutions reported holding it in 13F filings for Q2 2026, worth $2.07B in total; no superinvestor holds it.
Holders of 5% or more of BCAX
Holders whose latest Schedule 13D or 13G filing reports 5% or more of Bicara Therapeutics Inc., largest stake first. The change is against the holder's previous filing.
| Holder | Latest form | Stake | Change | First filed | Latest filing | Filing |
|---|---|---|---|---|---|---|
| Ra Capital Management, L.P. | 13D/A | 11.50%7.28M shares | – | Sep 23, 20242 filings | Mar 2, 2026 | SEC |
| Invus Global Management, LLC | 13G/A | 9.60%5.22M shares | – | Sep 26, 20242 filings | Jul 31, 2025 | SEC |
| Vestal Point Capital, LP | 13G/A | 8.30%5.42M shares | +1.80 ppfrom 6.50% | May 15, 20254 filings | May 15, 2026 | SEC |
| Deep Track Capital, LP | 13G/A | 6.21%4.06M shares | +1.19 ppfrom 5.02% | Feb 12, 20262 filings | May 15, 2026 | SEC |
| BlackRock, Inc. | 13G | 5.40%3.54M shares | New | Jul 27, 20261 filing | Jul 27, 2026 | SEC |
Stakes are as of each holder's latest filing. Holders whose last filing was in the old format (before December 18, 2024) have no stake on record and are not listed, and after an acquisition or delisting holders usually stop filing.
13D and 13G filings
27 Schedule 13D and 13G filings on Bicara Therapeutics Inc., newest first, including old-format filings without a stake.
| Filed (ET) | Filer | Form | Stake | Change | Event date | Filing |
|---|---|---|---|---|---|---|
| Oct 7, 20262:57 PM ET | T. Rowe Price Investment Management, Inc. | 13G/A | 4.20%2.80M shares | −5.90 ppfrom 10.10%Below 5% | Sep 30, 2026 | SEC |
| Aug 13, 202612:42 PM ET | Janus Henderson Group PLC | 13G/A | 4.80%3.17M shares | −0.30 ppfrom 5.10%Below 5% | Jun 30, 2026 | SEC |
| Jul 27, 20264:25 PM ET | BlackRock, Inc. | 13G | 5.40%3.54M shares | New | Jun 30, 2026 | SEC |
| May 15, 20265:06 PM ET | Vestal Point Capital, LPand 1 other | 13G/A | 8.30%5.42M shares | +1.80 ppfrom 6.50% | Mar 31, 2026 | SEC |
| May 15, 202611:43 AM ET | Janus Henderson Group PLC | 13G | 5.10%3.34M shares | New | Mar 31, 2026 | SEC |
| May 15, 20268:38 AM ET | Deep Track Capital, LPand 2 others | 13G/A | 6.21%4.06M shares | +1.19 ppfrom 5.02% | Mar 31, 2026 | SEC |
| May 8, 20269:22 PM ET | Red Tree GP, LLCand 2 others | 13G/A | 4.80%3.17M shares | –Below 5% | Mar 31, 2026 | SEC |
| May 6, 202611:00 AM ET | FMR LLCand 1 other | 13G/A | 3.20%2.10M shares | −2.90 ppfrom 6.10%Below 5% | Mar 31, 2026 | SEC |
| Apr 8, 20263:26 PM ET | T. Rowe Price Investment Management, Inc. | 13G/A | 10.10%6.61M shares | +4.20 ppfrom 5.90% | Mar 31, 2026 | SEC |
| Mar 2, 20264:25 PM ET | Ra Capital Management, L.P.and 3 others | 13D/A | 11.50%7.28M shares | – | Feb 26, 2026 | SEC |
| Feb 17, 20264:10 PM ET | Vestal Point Capital, LPand 1 other | 13G/A | 6.50%3.58M shares | −2.70 ppfrom 9.20% | Dec 31, 2025 | SEC |
| Feb 17, 202610:28 AM ET | T. Rowe Price Investment Management, Inc. | 13G | 5.90%3.24M shares | New | Dec 31, 2025 | SEC |
| Feb 12, 20264:19 PM ET | Deep Track Capital, LPand 2 others | 13G | 5.02%2.75M shares | New | Feb 5, 2026 | SEC |
| Feb 5, 20261:16 PM ET | FMR LLCand 1 other | 13G/A | 6.10%3.35M shares | +1.00 ppfrom 5.10% | Dec 31, 2025 | SEC |
| Aug 14, 20253:57 PM ET | Vestal Point Capital, LPand 1 other | 13G/A | 9.20%5.00M shares | +4.10 ppfrom 5.10% | Jun 30, 2025 | SEC |
| Jul 31, 20252:56 PM ET | Invus Global Management, LLCand 7 others | 13G/A | 9.60%5.22M shares | – | Jun 30, 2025 | SEC |
| Jul 17, 202511:11 AM ET | FMR LLCand 1 other | 13G | 5.10%2.76M shares | +0.40 ppfrom 4.70% | Jul 10, 2025 | SEC |
| Jul 17, 202511:08 AM ET | FMR LLCand 1 other | 13G/A | 4.70%2.54M shares | −1.90 ppfrom 6.60%Below 5% | Jun 30, 2025 | SEC |
| May 15, 20254:13 PM ET | Vestal Point Capital, LPand 1 other | 13G | 5.10%2.77M shares | New | Mar 31, 2025 | SEC |
| May 12, 202510:28 AM ET | FMR LLCand 1 other | 13G/A | 6.60%3.61M shares | +1.40 ppfrom 5.20% | Mar 31, 2025 | SEC |
| Mar 3, 20259:14 AM ET | FMR LLCand 1 other | 13G | 5.20%2.80M shares | +1.30 ppfrom 3.90% | Feb 24, 2025 | SEC |
| Feb 12, 20259:16 AM ET | FMR LLCand 1 other | 13G/A | 3.90%2.12M shares | –Below 5% | Dec 31, 2024 | SEC |
| Sep 26, 2024 | Invus Global Management, LLC | 13GOld format | – | New | – | SEC |
| Sep 26, 2024 | Red Tree GP, LLC | 13GOld format | – | New | – | SEC |
| Sep 23, 2024 | Ra Capital Management, L.P. | 13DOld format | – | New | – | SEC |
| Sep 18, 2024 | TPG GP A, LLC | 13DOld format | – | New | – | SEC |
| Sep 18, 2024 | FMR LLC | 13GOld format | – | New | – | SEC |
Form 144: proposed insider sales
62 notices from officers, directors and other affiliates planning to sell Bicara Therapeutics Inc. shares, newest first.
| Filed (ET) | Seller | Shares to sell | Market value | Planned sale | Broker | Filing |
|---|---|---|---|---|---|---|
| Oct 21, 20264:55 PM ET | David RabenOfficer | 24.8K | $449.0K | Oct 21, 2026 | Morgan Stanley Smith Barney LLC Executive Financial Services | SEC |
| Sep 8, 20264:05 PM ET | Hyep IvanOfficer | 12.5K | $283.0K | Sep 8, 202610b5-1 | UBS Financial Services, Inc. | SEC |
| Sep 8, 20264:04 PM ET | Cohlhepp RyanOfficer · Director | 17.5K | $396.2K | Sep 8, 202610b5-1 | UBS Financial Services, Inc | SEC |
| Aug 10, 20264:18 PM ET | Hyep IvanOfficer | 12.5K | $347.9K | Aug 10, 202610b5-1 | UBS Financial Services, Inc. | SEC |
| Aug 10, 20264:16 PM ET | Cohlhepp RyanOfficer · Director | 18.8K | $521.8K | Aug 10, 202610b5-1 | UBS Financial Services, Inc | SEC |
| Aug 10, 20264:09 PM ET | Mazumdar ClaireOfficer · Director | 10.0K | $278.3K | Aug 10, 202610b5-1 | UBS Financial Services, Inc. | SEC |
| Jul 10, 20264:04 PM ET | Mazumdar ClaireOfficer · Director | 10.0K | $296.8K | Jul 10, 202610b5-1 | UBS Financial Services, Inc. | SEC |
| Jul 8, 20264:30 PM ET | David RabenOfficer | 50.0K | $1.43M | Jul 8, 2026 | Morgan Stanley Smith Barney LLC Executive Financial Services | SEC |
| Jul 8, 20264:11 PM ET | Cohlhepp RyanOfficer · Director | 28.8K | $869.7K | Jul 8, 202610b5-1 | UBS Financial Services, Inc | SEC |
| Jul 8, 20264:05 PM ET | Hyep IvanOfficer | 28.0K | $847.0K | Jul 8, 202610b5-1 | UBS Financial Services, Inc. | SEC |
| Jul 7, 20264:06 PM ET | Lara MeisnerOfficer | 1.00K | $29.8K | Jul 7, 2026 | Morgan Stanley Smith Barney LLC Executive Financial Services | SEC |
| Jun 25, 20264:07 PM ET | David RabenOfficer | 50.0K | $1.32M | Jun 25, 2026 | Morgan Stanley Smith Barney LLC Executive Financial Services | SEC |
| Jun 1, 20264:02 PM ET | Meisner LaraFormer Chief Legal Officer | 71.4K | $1.47M | Jun 1, 2026 | Morgan Stanley Smith Barney LLC | SEC |
| May 26, 20264:02 PM ET | Raben DavidOfficer | 5.50K | $120.0K | May 26, 202610b5-1 | UBS Financial Services Inc. | SEC |
| May 21, 20264:02 PM ET | Hyep IvanOfficer | 9.20K | $187.9K | May 21, 202610b5-1 | UBS Financial Services, Inc. | SEC |
| May 18, 20264:18 PM ET | Mazumdar ClaireOfficer · Director | 15.0K | $313.8K | May 18, 202610b5-1 | UBS Financial Services, Inc. | SEC |
| May 15, 20264:14 PM ET | Cohlhepp RyanOfficer · Director | 12.5K | $253.9K | May 15, 202610b5-1 | UBS Financial Services, Inc | SEC |
| Apr 27, 20264:09 PM ET | Raben DavidOfficer | 5.50K | $125.8K | Apr 27, 202610b5-1 | UBS Financial Services Inc. | SEC |
| Apr 21, 20264:09 PM ET | Hyep IvanOfficer | 9.20K | $213.2K | Apr 21, 202610b5-1 | UBS Financial Services, Inc. | SEC |
| Apr 20, 20264:02 PM ET | Mazumdar ClaireOfficer · Director | 15.0K | $356.1K | Apr 20, 202610b5-1 | UBS Financial Services, Inc. | SEC |
| Apr 15, 20264:06 PM ET | Cohlhepp RyanOfficer · Director | 12.5K | $287.3K | Apr 15, 202610b5-1 | UBS Financial Services, Inc | SEC |
| Mar 25, 20264:01 PM ET | Raben DavidOfficer | 5.50K | $104.2K | Mar 25, 202610b5-1 | UBS Financial Services Inc. | SEC |
| Mar 23, 20264:04 PM ET | Hyep IvanOfficer | 9.20K | $171.1K | Mar 23, 202610b5-1 | UBS Financial Services, Inc. | SEC |
| Mar 20, 20264:08 PM ET | Mazumdar ClaireOfficer · Director | 1.60K | $30.2K | Mar 20, 202610b5-1 | UBS Financial Services, Inc. | SEC |
| Mar 19, 20264:27 PM ET | Mazumdar ClaireOfficer · Director | 6.91K | $129.7K | Mar 19, 202610b5-1 | UBS Financial Services, Inc. | SEC |
Showing the latest 25. See the BCAX notices from the last 12 months